What is the Joe Tippens Protocol?

The Joe Tippens Protocol is an alternative cancer treatment regimen that includes fenbendazole (an anti-parasitic drug), vitamin E, bioavailable curcumin, and CBD oil. It was created by Joe Tippens, who claimed to have cured his terminal small-cell lung cancer in 2016.

What is the fenbendazole dosage in the Joe Tippens Protocol?

The typical dosage is 222mg of fenbendazole (one packet of Panacur C) taken daily for 3 days, then 4 days off. This is repeated weekly. Always consult your doctor before starting any protocol.

What CBD oil does Joe Tippens use?

Joe Tippens uses high-quality CBD oil capsules (25mg).

Is fenbendazole FDA approved for cancer treatment?

No. Fenbendazole is FDA approved only as a veterinary anti-parasitic drug. It is not approved for cancer treatment in humans. There is insufficient clinical evidence from randomized controlled trials to support its use as a cancer treatment.

What does the research say about fenbendazole and cancer?

Laboratory studies show fenbendazole can kill cancer cells in petri dishes and slow tumor growth in mice. However, there is currently no evidence from human clinical trials proving it is effective for treating cancer in people. More research is needed.

What are the ingredients in the Joe Tippens Protocol?

The protocol includes: Fenbendazole (222mg, 3 days on/4 days off), Vitamin E (800 IU daily), Bioavailable Curcumin (1200mg daily), and CBD Oil (25mg daily).

Where can I buy CBD oil for the protocol?

We recommend high-quality CBD oil from Laura's Mercantile.

Is the Joe Tippens Protocol safe?

Fenbendazole is not FDA approved for human use. Some patients have experienced liver injury. Always consult your doctor before starting any protocol. Do not replace conventional cancer treatment without medical advice.

← Back to BlogSafety Alerts

South Korea Issues Warning on Fenbendazole Use

2025-02-15•5 min read

Understanding the South Korea Warning

In late 2024, South Korea's Ministry of Food and Drug Safety issued a significant warning regarding fenbendazole use, documenting cases of severe liver injury among users.

What Was Reported

Korean health authorities reported several cases of:

Acute liver injury

Elevated liver enzymes

Hospitalizations requiring medical intervention

Key Takeaways

1. **Fenbendazole is not approved for human cancer treatment**

2. **Liver function should be monitored** if using this protocol

3. **Quality and sourcing matter** - products vary significantly

4. **Consult healthcare providers** before starting any protocol

Our Recommendation

If you choose to explore this protocol:

Get baseline liver function tests

Monitor regularly during use

Work with a healthcare provider

Report any adverse effects

This information should be weighed alongside the anecdotal reports of positive outcomes. The decision is personal and should involve qualified medical guidance.